Clinical trial
Bless Study (BLeeding Events and Maintenance DoSe of PraSugrel)
NCT01790854 is registered in ClinicalTrials.gov with David Antoniucci as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bless Study (BLeeding Events and Maintenance DoSe of PraSugrel)
- Lead sponsor
- David Antoniucci
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2012
- Completion date
- October 31, 2014
- Enrollment
- 195 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, adverse reaction to antiplatelet agent